Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03622814 · ClinicalTrials.gov registry record · NA
Partners at Meals - Respite Care and Home (PAM)
A NA study of Weight Loss and Dementia Alzheimer Type, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT03622814: Completed NA study of Weight Loss and Dementia Alzheimer Type, sponsored by Medical University of South Carolina.
NCT03622814 is a NA study of Weight Loss and Dementia Alzheimer Type that has completed, run by Medical University of South Carolina. The registered enrollment target is 106 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03622814, a NA study of Weight Loss and Dementia Alzheimer Type, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study was to test the efficacy of a mealtime intervention in respite care centers for people with dementia and their caregivers. Mealtimes become more challenging as dementia progresses causing nutritional and behavioral issues in the affected individuals. Using a train-the-trainer program built on the Partners at Meals model, volunteers in respite centers partner worked with caregivers and developed a mealtime plan that builds on the strengths of the person with dementia (PWD), and developed a supportive environment for change. A tele-health component was involved in the communication between the respite center volunteers/staff and families. Recruitment was limited to people attending the particular respite centers. Two large RCCs with a total of 5 sites of care in suburban and rural areas of SC were the sites of this project.
Primary Outcome
Assessed by unit of measure in pounds; reported as mean difference in pounds from baseline to follow-up at 6 months
Conditions Studied
Interventions
- BEHAVIORAL Partners at Meals
- BEHAVIORAL Enhanced Usual Condition
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT03622814 record still lists
NCT03622814 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Partners at Meals is the first listed.
NCT03622814 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT03622814 about?
NCT03622814 is a clinical study titled "Partners at Meals - Respite Care and Home (PAM)". The goal of this study was to test the efficacy of a mealtime intervention in respite care centers for people with dementia and their caregivers. Mealtimes become more challenging as dementia progresses causing nutritional and behavioral issues in the affected individuals. Using a train-the-trainer ...
What is the current status of trial NCT03622814?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2017-08-15. Estimated completion is 2023-06-30.
What conditions does trial NCT03622814 study?
This clinical trial studies the following conditions: Weight Loss, Dementia Alzheimer Type.
What interventions are being tested in trial NCT03622814?
The interventions under investigation include: Partners at Meals (BEHAVIORAL), Enhanced Usual Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03622814?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03622814 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03622814's enrollment target sits among peer trials
106 46th of 116 higher than 71 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI